MedTrace Logo

Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate Cancer

NCT00621413 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2021-04-19

No results posted yet for this study

Summary

The purpose of this study is to observe PSA response and incidence of side effects in patients diagnosed with intermediate to high risk prostate cancer and treated with Cesium-131 in combination of external beam therapy.

Conditions

Sponsors & Collaborators

  • Swedish Medical Center

    collaborator OTHER

  • IsoRay Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • John Sylvester, MD · Seattle Prostate Institute / Swedish Hospital

  • Steve Kurtzman, MD · Mills Peninsula Hospital

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2007-02-28
Completion
2007-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00621413 on ClinicalTrials.gov